SOCS3 and SOCS1 expression has been widely investigated in a number of cancers, including breast cancer, multiple myeloma, hepatocarcinoma and lymphoma, where their absence suggests a tumor-suppressor function [29, 30, 31, 32]. Here, SOCS1 is linked to plasma cell myeloma.